Form 8-K - Current report:
SEC Accession No. 0001104659-26-003211
Filing Date
2026-01-13
Accepted
2026-01-13 12:38:14
Documents
22
Period of Report
2026-01-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dwtx-20260109x8k.htm   iXBRL 8-K 69831
2 EX-5.1 dwtx-20260109xex5d1.htm EX-5.1 20947
3 EX-10.1 dwtx-20260109xex10d1.htm EX-10.1 290364
4 EX-10.2 dwtx-20260109xex10d2.htm EX-10.2 127811
5 EX-10.3 dwtx-20260109xex10d3.htm EX-10.3 118624
6 EX-10.4 dwtx-20260109xex10d4.htm EX-10.4 179259
7 EX-10.5 dwtx-20260109xex10d5.htm EX-10.5 125052
8 EX-99.1 dwtx-20260109xex99d1.htm EX-99.1 17751
9 GRAPHIC dwtx-20260109xex5d1001.jpg GRAPHIC 3779
10 GRAPHIC dwtx-20260109xex5d1004.jpg GRAPHIC 5437
11 GRAPHIC dwtx-20260109xex99d1002.jpg GRAPHIC 4807
  Complete submission text file 0001104659-26-003211.txt   1268396

Data Files

Seq Description Document Type Size
12 EX-101.SCH dwtx-20260109.xsd EX-101.SCH 2655
13 EX-101.LAB dwtx-20260109_lab.xml EX-101.LAB 15271
14 EX-101.PRE dwtx-20260109_pre.xml EX-101.PRE 9643
24 EXTRACTED XBRL INSTANCE DOCUMENT dwtx-20260109x8k_htm.xml XML 4623
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Dogwood Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

EIN.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39811 | Film No.: 26529210
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)